A novel finding of this study was the upregulation of 9-cis RA upon TGFβ treatment in pancreatic adenocarcinoma cells that harbor a mutant KRAS gene, while these changes were not apparent in Panc02.13 cells. Here, KRAS is linked to pancreatic adenocarcinoma.